Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2014


Biosimilars and Biobetters USA

07 Apr 2014 - 08 Apr 2014 - Iselin, NJ, USA



Bookmark and Share


Through a series of exciting panel discussions, presentations and workshops, delivered by true industry experts and players, this meeting will offer effective strategies and solutions for developing cost effective biosimilars for the future.

Read more:

After the phenomenal success of our Biosimilars and Biobetters event hosted in London in October, the SMi Group is delighted to announce the launch of the Biosimilars & Biobetters Conference in Iselin, New Jersey, USA, in April 2014. Registration is now open.

Through a series of exciting panel discussions, presentations and workshops, delivered by true industry experts and players, the Biosimilars and Biobetters USA conference will offer effective strategies and solutions for developing cost effective biosimilars for the future.

Event’s website: www.smi-online.co.uk/2014biosimilars_usa20.asp 

Benefits of attending:

-      Gain up to date insight into the regulatory landscape and how it is effecting the industry

-      Evaluate commercialization and development strategies to gain a competitive advantage 

-      Calculate possible revenue streams from biosimilar production

-      Discover what lessons have been learned so far and what the future holds 

-      Boost your industry knowledge and relationships by networking and learning from key industry and academic leaders

Key speakers include:

-      Dr Richard Dicicco, Chairman, Harvest Moon Pharmaceuticals

-      Dr John Pakulski, Senior Director, and Head US Biopharmaceutical Regulatory Affairs, Sandoz

-      Rodeina Challand, Executive Director, Biosimilars Development, Scientific Affairs, PRA International

-      Dr Stanley (SeungSuh) Hong, President, Research and Development, Celltrion Inc.

-      Paul Ashton, President & CEO, pSivida

-      Peter Pitts, President, Center for Medicine in the Public Interest (Former FDA Associate Commissioner)

-      Douglas M. Long, Vice President, Industry Relations, IMS Health

-      Dr Rakesh Dixit, Vice President, Research and Development Head, Global Biologics Safety Assessment, MedImmune (AstraZeneca Biologics), and many others. 

Don’t miss a chance to visit 2 interactive post-conference workshops:

A.    Differentiation Strategies for the Generics Industry. Workshop Leader: Asa Cox, Founder & CEO, Generic Pharma 2.0

B.    Launching a Biosimilar in an Innovator v. Generic World. Workshop Leader: Kristie Kuhl, JD, Executive VP, Makovsky

For further information please contact Jonathan Collins on +44 (0)20 7827 6734 or email: pharma@smiconferences.co.uk  



Further information
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Blood Pressure Drug May Boost Effectiveness of Lung Cancer Treatment
Researchers at Imperial College London have suggested that the blood pressure drug may make a type of lung cancer treatment more effective.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
New Discovery May Benefit Farmers Worldwide
Scientists have shown how a crop-microbe 'team' protect against fungal infection.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!